Saturday, 23 May, 2026
Cheating Time Itself? Sam Altman’s $180 Million Bet on Living Longer
By TechShots Studio
Sam Altman is reportedly investing $180 million into anti-ageing and longevity research, signaling Silicon Valley’s growing obsession with extending human lifespan. The initiative focuses on advanced biotech and health innovations aimed at slowing ageing and improving long-term wellness, as tech leaders increasingly view longevity science as the next major frontier after AI.
Read full story at cioeet